Investors Are Looking to Axcelis as the Next Wave of Chip Growth Builds

REINHART PARTNERS, LLC. significantly increased its stake in Axcelis Technologies (ACLS) during Q3 2025, acquiring an additional 91,788 shares in an estimated $7.39 million transaction. This strategic move elevated Axcelis Technologies to the fund's largest holding, now comprising 5.1% of its 13F reportable AUM with a total value of $157.23 million. The increased conviction highlights a focus on Axcelis's specialized role in semiconductor ion implantation equipment, despite the stock's recent underperformance relative to the S&P 500.

Analysis

REINHART PARTNERS, LLC. significantly increased its position in Axcelis Technologies (ACLS) during Q3 2025, acquiring an additional 91,788 shares in an estimated $7.39 million transaction. This strategic move elevated ACLS to the fund's largest holding, now comprising 5.1% of its 13F reportable AUM with a total value of $157.23 million. This substantial allocation signals strong conviction from a seasoned institutional investor despite recent stock underperformance.

Axcelis Technologies specializes in ion implantation equipment, a critical component in semiconductor chip fabrication, and offers robust aftermarket lifecycle services. The company's focused expertise in this niche provides a competitive advantage against broader equipment manufacturers like Applied Materials and Lam Research. Its TTM revenue stands at $896.09 million with a net income of $158.49 million, indicating a profitable operation within its specialized segment.

The company is well-positioned to capitalize on the increasing demand for power semiconductors, driven by electric vehicles and industrial applications. Its established installed base and recurring service revenue streams offer stability through market cycles. However, ACLS shares were down 7.6% year-over-year as of October 27, 2025, underperforming the S&P 500 by 25.8 percentage points, suggesting market skepticism or broader industry headwinds.

Key Decisions for Investors

• Investors should consider the significant increase in REINHART PARTNERS' stake, making ACLS its top holding, as a strong signal of institutional confidence despite recent stock underperformance.
• Evaluate Axcelis Technologies' specialized market position in critical ion implantation equipment and its leverage to the growing power semiconductor sector for long-term growth potential.
• Monitor the company's financial performance, particularly its aftermarket service revenue stability, and broader semiconductor industry cycles for sustained competitive advantage.
• Assess the current valuation relative to its $83.25 share price and 7.6% year-over-year decline, considering potential entry points or re-evaluating existing positions.